US2008214788A1PendingUtilityA1

Interferon-like protein zcyto21

Assignee: ZYMOGENETICS INCPriority: Jun 30, 2000Filed: Jan 9, 2008Published: Sep 4, 2008
Est. expiryJun 30, 2020(expired)· nominal 20-yr term from priority
A61P 31/12C07K 2319/00C07K 14/52C07K 14/47A61P 25/28
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to polynucleotide and polypeptide molecules for Zcyto21, an interferon-like protein, which is most closely related to interferon-α at the amino acid sequence level. The present invention also includes antibodies to the Zcyto21 polypeptides, and methods of using the polynucleotides and polypeptides.

Claims

exact text as granted — not AI-modified
1 . An isolated antibody or antibody fragment that specifically binds with a polypeptide consisting of an amino acid sequence having at least 95% sequence identity to amino acid residues 20-200 of SEQ ID NO:2. 
     
     
         2 . The isolated antibody of  claim 1  wherein the antibody has at least 96% sequence identity to amino acid residues 20-200 of SEQ ID NO:2. 
     
     
         3 . The isolated antibody of  claim 1  wherein the antibody has at least 97% sequence identity to amino acid residues 20-200 of SEQ ID NO:2. 
     
     
         4 . The isolated antibody of  claim 1  wherein the antibody has at least 98% sequence identity to amino acid residues 20-200 of SEQ ID NO:2. 
     
     
         5 . The isolated antibody of  claim 1  wherein the antibody has at least 99% sequence identity to amino acid residues 20-200 of SEQ ID NO:2. 
     
     
         6 . The isolated antibody of  claim 1  wherein the antibody is monoclonal. 
     
     
         7 . The isolated antibody of  claim 1  wherein the antibody is humanized. 
     
     
         8 . The isolated antibody of  claim 1  wherein the antibody is polyclonal. 
     
     
         9 . The isolated antibody of  claim 1  wherein the antibody fragment is a F(ab′) 2 , a Fab, or a single chain antibody. 
     
     
         10 . The isolated antibody of  claim 1  wherein the amino acid sequence consists of amino acid residues 20-200 of SEQ ID NO:2.

Join the waitlist — get patent alerts

Track US2008214788A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.